JP Morgan Chase’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.86M | Sell |
164,778
-8,899
| -5% | -$243K | ﹤0.01% | 3334 |
|
|
2025
Q4 | $4.72M | Sell |
173,677
-11,098
| -6% | -$292K | ﹤0.01% | 3362 |
|
|
2025
Q3 | $4.78M | Sell |
184,775
-49,046
| -21% | -$1.14M | ﹤0.01% | 3411 |
|
|
2025
Q2 | $4.76M | Sell |
233,821
-7,533
| -3% | -$147K | ﹤0.01% | 3224 |
|
|
2025
Q1 | $4.38M | Buy |
241,354
+155,809
| +182% | +$3.48M | ﹤0.01% | 3268 |
|
|
2024
Q4 | $2.16M | Buy |
85,545
+34,670
| +68% | +$942K | ﹤0.01% | 4100 |
|
|
2024
Q3 | $1.73M | Sell |
50,875
-5,489
| -10% | -$209K | ﹤0.01% | 4113 |
|
|
2024
Q2 | $2.09M | Buy |
56,364
+9,609
| +21% | +$363K | ﹤0.01% | 3756 |
|
|
2024
Q1 | $1.96M | Sell |
46,755
-28,715
| -38% | -$1.18M | ﹤0.01% | 3860 |
|
|
2023
Q4 | $2.99M | Buy |
75,470
+12,793
| +20% | +$376K | ﹤0.01% | 3520 |
|
|
2023
Q3 | $1.72M | Sell |
62,677
-37,146
| -37% | -$1.16M | ﹤0.01% | 3651 |
|
|
2023
Q2 | $3.39M | Buy |
99,823
+28,210
| +39% | +$951K | ﹤0.01% | 3152 |
|
|
2023
Q1 | $2.58M | Buy |
71,613
+23,558
| +49% | +$1.02M | ﹤0.01% | 3355 |
|
|
2022
Q4 | $2.14M | Buy |
48,055
+5,156
| +12% | +$184K | ﹤0.01% | 3504 |
|
|
2022
Q3 | $1.21M | Buy |
42,899
+553
| +1% | +$17K | ﹤0.01% | 3865 |
|
|
2022
Q2 | $1.14M | Buy |
42,346
+7,458
| +21% | +$217K | ﹤0.01% | 3981 |
|
|
2022
Q1 | $1.19M | Sell |
34,888
-92,946
| -73% | -$2.97M | ﹤0.01% | 4139 |
|
|
2021
Q4 | $4.94M | Sell |
127,834
-83,619
| -40% | -$3.64M | ﹤0.01% | 3069 |
|
|
2021
Q3 | $11.4M | Buy |
211,453
+196,264
| +1,292% | +$9.21M | ﹤0.01% | 2269 |
|
|
2021
Q2 | $507K | Buy |
15,189
+15,081
| +13,964% | +$414K | ﹤0.01% | 4687 |
|
|
2021
Q1 | $2K | Sell |
108
-59
| -35% | -$1.35K | ﹤0.01% | 5932 |
|
|
2020
Q4 | $3K | Buy |
167
+101
| +153% | +$1.82K | ﹤0.01% | 5487 |
|
|
2020
Q3 | $1K | Hold |
66
| – | – | ﹤0.01% | 5404 |
|
|
2020
Q2 | $1K | Hold |
66
| – | – | ﹤0.01% | 5289 |
|
|
2020
Q1 | $0 | Hold |
66
| – | – | ﹤0.01% | 5341 |
|
|
2019
Q4 | $0 | Hold |
66
| – | – | ﹤0.01% | 5623 |
|
|
2019
Q3 | $0 | Hold |
66
| – | – | ﹤0.01% | 5739 |
|
|
2019
Q2 | $0 | Hold |
66
| – | – | ﹤0.01% | 5783 |
|
|
2019
Q1 | $0 | Sell |
66
-430
| -87% | -$2.26K | ﹤0.01% | 5780 |
|
|
2018
Q4 | $1K | Buy |
496
+370
| +294% | +$1.82K | ﹤0.01% | 5613 |
|
|
2018
Q3 | $0 | Buy |
126
+59
| +88% | +$413 | ﹤0.01% | 5675 |
|
|
2018
Q2 | $1K | Sell |
67
-66,012
| -100% | -$882K | ﹤0.01% | 5483 |
|
|
2018
Q1 | $2.31M | Buy |
66,079
+64,187
| +3,393% | +$2.49M | ﹤0.01% | 3165 |
|
|
2017
Q4 | $81K | Buy |
+1,892
| New | +$81K | ﹤0.01% | 4736 |
|
|
2017
Q2 | – | Sell |
-36,811
| Closed | -$1.99M | – | 4979 |
|
|
2017
Q1 | $1.99M | Sell |
36,811
-5,316
| -13% | -$277K | ﹤0.01% | 3040 |
|
|
2016
Q4 | $2.24M | Buy |
42,127
+1,880
| +5% | +$107K | ﹤0.01% | 2991 |
|
|
2016
Q3 | $2.44M | Sell |
40,247
-1,921
| -5% | -$120K | ﹤0.01% | 2686 |
|
|
2016
Q2 | $2.78M | Sell |
42,168
-3,841
| -8% | -$244K | ﹤0.01% | 2630 |
|
|
2016
Q1 | $2.61M | Buy |
46,009
+22,404
| +95% | +$2.52M | ﹤0.01% | 2564 |
|
|
2015
Q4 | $5.55M | Buy |
23,605
+2,598
| +12% | +$566K | ﹤0.01% | 2159 |
|
|
2015
Q3 | $3.32M | Buy |
21,007
+2,147
| +11% | +$608K | ﹤0.01% | 2487 |
|
|
2015
Q2 | $7.13M | Sell |
18,860
-4,837
| -20% | -$1.92M | ﹤0.01% | 2160 |
|
|
2015
Q1 | $9.91M | Sell |
23,697
-3,535
| -13% | -$1.26M | ﹤0.01% | 1905 |
|
|
2014
Q4 | $7.45M | Sell |
27,232
-5,486
| -17% | -$1.36M | ﹤0.01% | 2145 |
|
|
2014
Q3 | $6.36M | Sell |
32,718
-708
| -2% | -$154K | ﹤0.01% | 2207 |
|
|
2014
Q2 | $8.18M | Buy |
33,426
+21,836
| +188% | +$4.93M | ﹤0.01% | 1842 |
|
|
2014
Q1 | $3.07M | Buy |
11,590
+115
| +1% | +$44K | ﹤0.01% | 2354 |
|
|
2013
Q4 | $4.17M | Sell |
11,475
-8,134
| -41% | -$3.13M | ﹤0.01% | 2286 |
|
|
2013
Q3 | $10.4M | Sell |
19,609
-2,707
| -12% | -$928K | ﹤0.01% | 1736 |
|
|
2013
Q2 | $5.22M | Buy |
+22,316
| New | +$4.39M | ﹤0.01% | 2111 |
|
Other funds holding CLDX
KCM
VCM
CC
EP